Sage Therapeutics Inc (SAGE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

215 FIRST STREET CAMBRIDGE, MA 02142

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. The Company is pursuing new pathways with the goal of improving brain health, and its depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Its mission is to make medicines that matter so people can get better, sooner.

Data as of 2021-07-19 09:25:38 -0400
Market Cap2.792 Billion Shares Outstanding58.48 Million Avg 30-day Volume799.591 Thousand
P/E Ratio4.38245 Dividend Yield EPS11.66
Price/Sales2.51 Debt to Equity1.04 EBITDA663.629 Million
Price to Book Value1.39 Forward PE-0.11 Enterprise Value787.819 Million
Total Cash2.004 Billion Current Debt62.011 Million Gross Profit1.113 Billion
BETA0.83072 52-week High/Low98.39 / 43.74 Next Earnings Date2021-08-09 Price to Cash FLow (P/CF) -34.6342
Data provided by IEX Cloud
View SEC Filings from SAGE instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 6 -16.67% 4 (0.23%) 5 (0.29%) -20.0%
Funds Holding: 256 246 4.07% 74 (4.34%) 77 (4.47%) -3.9%
13F shares: 52.482 Million 53.457 Million -1.82% 17.392 Million 18.842 Million -7.7%
% Ownership 91.7152 33.4167 32.3271 3.37%
New Positions: 54 52 3.85% 17 19 -10.53%
Increased Positions 77 71 8.45% 22 19 15.79%
Closed Positions 42 32 31.25% 20 17 17.65%
Reduced Positions 84 84 0.0% 27 32 -15.63%
Total Calls 638.26 Thousand 601.951 Thousand 6.03% 271.22 Thousand 182.376 Thousand 48.71%
Total Puts 1.16 Million 607.874 Thousand 90.8% 501.859 Thousand 78.1 Thousand 542.59%
PUT/CALL Ratio 1.82 1.01 80.2% 1.85 0.43 330.23%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SAGE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SAGE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

28.5 Thousand total shares from 3 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

17 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

STARR KEVIN P

320,659 2021-06-16 2

FRATES JAMES M

2,845 2021-06-16 2

GREENE BARRY E PRESIDENT AND CEO

8,800 2021-06-16 4

KANES STEPHEN CHIEF MEDICAL OFFICER

10,791 2021-06-15 2

JONAS JEFFREY M CHIEF INNOVATION OFFICER

121,824 2021-06-15 3

ROBICHAUD ALBERT CHIEF SCIENTIFIC OFFICER

139,651 2021-06-15 2

IGUCHI KIMI CFO & TREASURER

117,160 2021-06-15 4

COOK ANNE MARIE SVP, GC & SECRETARY

4,973 2021-06-15 2

PAUL STEVEN M

10,000 2021-06-10 1

COLA MICHAEL F

10,000 2021-06-10 1

GERMANO GENO J

10,000 2021-06-10 1

GOLUMBESKI GEORGE

10,000 2021-06-10 2

BARRETT ELIZABETH

10,000 2021-06-10 2

CLOONAN MICHAEL CHIEF BUSINESS OFFICER

0 2021-02-10 1

BIOGEN INC.

BIOGEN MA INC.

  • 10% Owner
6,241,473 2020-12-31 1

NAYAK ASHA

0 2019-06-05 0

ANDERSON THOMAS SEE REMARKS

0 2017-02-06 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
3,170,750 2016-08-19 0

PIEN HOWARD H

0 2016-06-22 0

NELSEN ROBERT

  • Director
1,232,649 2015-11-09 0

ARCH VENTURE FUND VII LP

ARCH VENTURE PARTNERS VII, L.P.

ARCH VENTURE PARTNERS VII, LLC

CRANDELL KEITH

BYBEE CLINTON

  • 10% Owner
No longer subject to file 2015-06-18 0

STEBEN KENNETH E PRESIDENT

  • Officer
  • Director
  • 10% Owner
0 2010-12-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

FRATES JAMES M see footnote 2

2021-06-17 16:04:47 -0400 2021-06-16 P 1,810 $55.10 a 1,810 indirect 0.9845 2.5668 2.5668 6 -2.0921 3

JONAS JEFFREY M CHIEF INNOVATION OFFICER

2021-06-17 09:13:30 -0400 2021-06-16 M 12,000 d 46,587 direct

GREENE BARRY E PRESIDENT AND CEO

2021-06-17 09:14:33 -0400 2021-06-16 P 8,800 $56.32 a 8,800 direct 3.0995 3.3351 4.1146 3 0.0 1

IGUCHI KIMI CFO & TREASURER

2021-06-17 09:12:02 -0400 2021-06-16 M 2,000 $1.36 a 44,533 direct 3.0995 3.3351 4.1146 3 0.0 1

STARR KEVIN P

2021-06-17 09:15:13 -0400 2021-06-16 P 17,842 $56.05 a 320,659 direct 3.0995 3.3351 4.1146 3 0.0 1

JONAS JEFFREY M CHIEF INNOVATION OFFICER

2021-06-17 09:13:30 -0400 2021-06-16 M 12,000 $0.45 a 75,237 direct 3.0995 3.3351 4.1146 3 0.0 1

IGUCHI KIMI CFO & TREASURER

2021-06-17 09:12:02 -0400 2021-06-16 M 2,000 d 14,047 direct

KANES STEPHEN CHIEF MEDICAL OFFICER

2021-06-17 09:12:29 -0400 2021-06-15 F 1,001 $58.80 d 10,791 direct 3.0995 3.3351 4.1146 3 0.0 1

ROBICHAUD ALBERT CHIEF SCIENTIFIC OFFICER

2021-06-17 09:12:54 -0400 2021-06-15 A 4,000 a 140,795 direct 3.0995 3.3351 4.1146 3 0.0 1

JONAS JEFFREY M CHIEF INNOVATION OFFICER

2021-06-17 09:13:30 -0400 2021-06-15 F 3,093 $58.80 d 63,237 direct 3.0995 3.3351 4.1146 3 0.0 1

COOK ANNE MARIE SVP, GC & SECRETARY

2021-06-17 09:14:09 -0400 2021-06-15 A 4,000 a 6,117 direct 3.0995 3.3351 4.1146 3 0.0 1

IGUCHI KIMI CFO & TREASURER

2021-06-17 09:12:02 -0400 2021-06-15 M 3,000 d 16,047 direct

IGUCHI KIMI CFO & TREASURER

2021-06-17 09:12:02 -0400 2021-06-15 A 3,500 a 43,355 direct 3.0995 3.3351 4.1146 3 0.0 1

KANES STEPHEN CHIEF MEDICAL OFFICER

2021-06-17 09:12:29 -0400 2021-06-15 A 3,500 a 11,792 direct 3.0995 3.3351 4.1146 3 0.0 1

JONAS JEFFREY M CHIEF INNOVATION OFFICER

2021-06-17 09:13:30 -0400 2021-06-15 A 10,000 a 66,330 direct 3.0995 3.3351 4.1146 3 0.0 1

IGUCHI KIMI CFO & TREASURER

2021-06-17 09:12:02 -0400 2021-06-15 M 3,000 $1.36 a 39,855 direct 3.0995 3.3351 4.1146 3 0.0 1

ROBICHAUD ALBERT CHIEF SCIENTIFIC OFFICER

2021-06-17 09:12:54 -0400 2021-06-15 F 1,144 $58.80 d 139,651 direct 3.0995 3.3351 4.1146 3 0.0 1

COOK ANNE MARIE SVP, GC & SECRETARY

2021-06-17 09:14:09 -0400 2021-06-15 F 1,144 $58.80 d 4,973 direct 3.0995 3.3351 4.1146 3 0.0 1

IGUCHI KIMI CFO & TREASURER

2021-06-17 09:12:02 -0400 2021-06-15 F 822 $58.80 d 42,533 direct 3.0995 3.3351 4.1146 3 0.0 1

BARRETT ELIZABETH

2021-06-11 16:09:36 -0400 2021-06-10 A 10,000 a 10,000 direct

COLA MICHAEL F

2021-06-11 16:11:01 -0400 2021-06-10 A 10,000 a 10,000 direct

PAUL STEVEN M

2021-06-11 16:08:03 -0400 2021-06-10 A 10,000 a 10,000 direct

GOLUMBESKI GEORGE

2021-06-11 16:11:29 -0400 2021-06-10 A 10,000 a 10,000 direct

GERMANO GENO J

2021-06-11 16:09:08 -0400 2021-06-10 A 10,000 a 10,000 direct

STARR KEVIN P

2021-06-11 16:07:17 -0400 2021-06-10 A 10,000 a 10,000 direct

FRATES JAMES M

2021-06-11 16:11:58 -0400 2021-06-10 A 10,000 a 10,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SAGE THERAPEUTICS INC SAGE 2021-07-23 22:15:03 UTC -0.3065 0.3865 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 21:45:03 UTC -0.3065 0.3865 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 21:15:03 UTC -0.3065 0.3865 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 20:45:03 UTC -0.3065 0.3865 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 20:15:05 UTC -0.3065 0.3865 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 19:45:03 UTC -0.3065 0.3865 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 19:15:03 UTC -0.3065 0.3865 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 18:45:03 UTC -0.3065 0.3865 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 18:15:03 UTC -0.3065 0.3865 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 17:45:03 UTC -0.3065 0.3865 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 17:15:02 UTC -0.3065 0.3865 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 16:45:02 UTC -0.3065 0.3865 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 16:15:03 UTC -0.3065 0.3865 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 15:45:02 UTC -0.3065 0.3865 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 15:15:03 UTC -0.3065 0.3865 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 14:45:03 UTC -0.5608 0.6408 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 14:15:03 UTC -0.5608 0.6408 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 13:45:03 UTC -0.5608 0.6408 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 13:15:03 UTC -0.5608 0.6408 1000000
SAGE THERAPEUTICS INC SAGE 2021-07-23 12:45:03 UTC -0.5608 0.6408 1000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
American Century Quantitative Equity Funds, Inc.- AC Alternatives Equity Market Neutral Fund SAGE -806.0 shares, $-58185.14 2019-12-31 N-PORT
American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund SAGE -621.0 shares, $-44829.99 2019-12-31 N-PORT
American Century Quantitative Equity Funds, Inc.- Core Equity Plus Fund SAGE -2065.0 shares, $-289698.85 2019-09-30 N-PORT
American Century Quantitative Equity Funds, Inc.- NT Core Equity Plus Fund SAGE -6074.0 shares, $-852121.46 2019-09-30 N-PORT
Trust for Professional Managers- Convergence Market Neutral Fund SAGE -1277.0 shares, $-66965.88 2020-08-31 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund SAGE -135.0 shares, $-3877.2 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund SAGE -118.0 shares, $-3388.96 2020-03-31 N-PORT
AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund SAGE -695.0 shares, $-97501.55 2019-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund SAGE -184.0 shares, $-5284.48 2020-03-31 N-PORT
RBB Fund, Inc.- Boston Partners Long/Short Research Fund SAGE -16431.0 shares, $-1396635.0 2021-02-28 N-PORT
TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund SAGE -2886.0 shares, $-216017.1 2021-03-31 N-PORT
Advanced Series Trust- AST Academic Strategies Asset Allocation Portfolio SAGE -4300.0 shares, $-321855.0 2021-03-31 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund SAGE -4639.0 shares, $-347229.15 2021-03-31 N-PORT
AQR Funds- AQR Multi-Asset Fund SAGE -1439.0 shares, $-107709.15 2021-03-31 N-PORT
JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund SAGE -4859.0 shares, $-363696.15 2021-03-31 N-PORT
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund SAGE -2304.0 shares, $-181463.04 2021-04-30 N-PORT
PACE SELECT ADVISORS TRUST- PACE Large Co Value Equity Investments SAGE -14580.0 shares, $-1148320.8 2021-04-30 N-PORT
VANGUARD TRUSTEES' EQUITY FUND- VANGUARD ALTERNATIVE STRATEGIES FUND SAGE -1859.0 shares, $-146414.84 2021-04-30 N-PORT

Elevate your investments